Medexus Pharmaceuticals (OTCMKTS:MEDXF) Trading Down 1% – Here’s Why

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF)’s share price traded down 1% on Monday . The company traded as low as $2.51 and last traded at $2.8920. 13,635 shares were traded during trading, an increase of 7% from the average session volume of 12,703 shares. The stock had previously closed at $2.9220.

Medexus Pharmaceuticals Trading Down 1.0%

The business’s 50-day moving average is $2.39 and its two-hundred day moving average is $2.13.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.

Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.